Letter to the editor: IL‐1 receptor antagonist plus pentoxifylline and zinc for severe alcoholic hepatitis—More questions than answers!
Satender Pal Singh, Ajay Kumar Mishra, Ankur Jindal – 30 June 2022
The clinical value of angiopoietin‐2 in liver diseases
Maham Farshidpour, Spencer Pace, Michael L. Volk – 30 June 2022
The challenges of ascites management: An Indian perspective
Anand V. Kulkarni, Madhumita Premkumar, Duvvur Nageshwar Reddy, Padaki Nagaraja Rao – 30 June 2022
Letter to the editor: Combination treatment with IL‐1 antagonist, pentoxifylline and zinc for severe alcoholic hepatitis: Are we there yet?
Shivam Gupta, Preetam Nath, Anil C. Anand – 30 June 2022
Improving quality of hepatitis B care in the Veteran's Health Administration
Karine Rozenberg‐Ben‐Dror, Marissa M. Maier, Lauren Beste, Elliott Lowy, Maggie Chartier, David Ross, Timothy R. Morgan – 30 June 2022
Letter to the editor: Some reflection on the research related to METTL1 promoting radiotherapy resistance in hepatocellular carcinoma
Fan Yang, Shi‐Tao Jiang, Yong‐Chang Zheng – 30 June 2022
Metabolic dysfunction‐associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortality
Laurens A. Kleef, Robert J. Knegt, Willem Pieter Brouwer – 30 June 2022
ALK1 controls hepatic vessel formation, angiodiversity, and angiocrine functions in hereditary hemorrhagic telangiectasia of the liver
Christian David Schmid, Victor Olsavszky, Manuel Reinhart, Vanessa Weyer, Felix A. Trogisch, Carsten Sticht, Manuel Winkler, Sina W. Kürschner, Johannes Hoffmann, Roxana Ola, Theresa Staniczek, Joerg Heineke, Beate K. Straub, Jens Mittler, Kai Schledzewski, Peter Dijke, Karsten Richter, Steven Dooley, Cyrill Géraud, Sergij Goerdt, Philipp‐Sebastian Koch – 30 June 2022
The diagnosis and management of nonalcoholic fatty liver disease: A patient‐friendly summary of the 2018 AASLD guidelines
Connor Griffin, Ranjeeta Bahirwani – 30 June 2022
COVID in Focus: Outpatient Therapeutics and Managing Liver Transplant Donors and Recipients
On April 13, 2022, AASLD hosted a webinar to provide an update on therapeutics and pathways to treat outpatients with COVID-19.